# Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

> **NCT02749032** · PHASE1 · COMPLETED · sponsor: **Michael A. Nauck** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** Mixed meal test
- **DRUG:** Vildagliptin
- **DRUG:** Sitagliptin
- **DRUG:** Placebo
- **DRUG:** Metformin
- **OTHER:** Diet and exercise

## Key facts

- **NCT ID:** NCT02749032
- **Lead sponsor:** Michael A. Nauck
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-03
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02749032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02749032, "Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02749032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*